Presentation is loading. Please wait.

Presentation is loading. Please wait.

Time frames for the application of noninvasive positive-pressure ventilation in acute respiratory failure (ARF) according to the severity and end-of-life.

Published byDulcie Park Modified over 5 years ago

Similar presentations

Presentation on theme: "Time frames for the application of noninvasive positive-pressure ventilation in acute respiratory failure (ARF) according to the severity and end-of-life."— Presentation transcript:

1 Time frames for the application of noninvasive positive-pressure ventilation in acute respiratory failure (ARF) according to the severity and end-of-life choices of patients. Time frames for the application of noninvasive positive-pressure ventilation in acute respiratory failure (ARF) according to the severity and end-of-life choices of patients. ETI: endotracheal intubation; IMV: invasive mechanical ventilation; NIV: noninvasive ventilation; EXT-F: extubation failure. Raffaele Scala, and Lara Pisani Eur Respir Rev 2018;27:180029 ©2018 by European Respiratory Society

Download ppt "Time frames for the application of noninvasive positive-pressure ventilation in acute respiratory failure (ARF) according to the severity and end-of-life."

Similar presentations

TEMPLATE DESIGN © 2008 www.PosterPresentations.com Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to COPD.

TEMPLATE DESIGN © Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to COPD.
นพ. ธรรมศักดิ์ ทวิช ศรี หน่วยเวชบำบัด วิกฤต ฝ่ายวิสัญญีวิทยา รพ. จุฬาลงกรณ์

นพ. ธรรมศักดิ์ ทวิช ศรี หน่วยเวชบำบัด วิกฤต ฝ่ายวิสัญญีวิทยา รพ. จุฬาลงกรณ์
Schönhofer, B; Kuhlen, R; Neumann, P; Westhoff, M; Berndt, C; Sitter, H Clinical Practice Guideline: Non-Invasive Mechanical Ventilation as Treatment of.

Schönhofer, B; Kuhlen, R; Neumann, P; Westhoff, M; Berndt, C; Sitter, H Clinical Practice Guideline: Non-Invasive Mechanical Ventilation as Treatment of.
호흡기내과 R1. 이정미. INTRODUCTION Acute respiratory failure (ARF) is the most common reason for admission in the intensive care unit (ICU), often requiring.

호흡기내과 R1. 이정미. INTRODUCTION Acute respiratory failure (ARF) is the most common reason for admission in the intensive care unit (ICU), often requiring.
Figure 1 Diagnostic flowchart for patients with suspected heart failure—showing alternative ‘echocardiography first’ (blue) or ‘natriuretic peptide first’

Figure 1 Diagnostic flowchart for patients with suspected heart failure—showing alternative ‘echocardiography first’ (blue) or ‘natriuretic peptide first’
J. R. Masclans, M. Pérez, J. Almirall, L. Lorente, A. Marqués, L

J. R. Masclans, M. Pérez, J. Almirall, L. Lorente, A. Marqués, L
Survival without tracheostomy

Survival without tracheostomy
acute, chronic, or acute on chronic.

acute, chronic, or acute on chronic.
Recent advances in mechanical ventilation

Recent advances in mechanical ventilation
Recommended algorithm for high-flow nasal cannula use in acute hypoxaemic respiratory failure in immunocompetent or immunocompromised patients. #: arterial.

Recommended algorithm for high-flow nasal cannula use in acute hypoxaemic respiratory failure in immunocompetent or immunocompromised patients. #: arterial.
Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.

Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.
Schematic representation of breathing levels during positive expiratory pressure in an obstructed patient. Schematic representation of breathing levels.

Schematic representation of breathing levels during positive expiratory pressure in an obstructed patient. Schematic representation of breathing levels.
Inclusion characteristics of a) previously diagnosed and b) newly diagnosed pulmonary arterial hypertension (PAH) patients enrolled in REVEAL. PVR: pulmonary.

Inclusion characteristics of a) previously diagnosed and b) newly diagnosed pulmonary arterial hypertension (PAH) patients enrolled in REVEAL. PVR: pulmonary.
Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.

Kaplan–Meier analysis of survival over 2 years of treatment with riociguat in the CHEST-2 study [54]. Kaplan–Meier analysis of survival over 2 years of.
Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.

Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.
Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.

Smoking cessation rate as point prevalence quit rate from year 1 to 5 in the Lung Health Study with 5,587 chronic obstructive pulmonary disease patients.
A) Experimental system to carry out a bench test of noninvasive ventilators. a) Experimental system to carry out a bench test of noninvasive ventilators.

A) Experimental system to carry out a bench test of noninvasive ventilators. a) Experimental system to carry out a bench test of noninvasive ventilators.
Electromagnetic navigation image: the icon representing the locatable guide (arrow) can be seen 3 mm away from the centre of a small pulmonary nodule in.

Electromagnetic navigation image: the icon representing the locatable guide (arrow) can be seen 3 mm away from the centre of a small pulmonary nodule in.
A–f) Respiratory mechanical measurements during incremental cycle exercise in patients with moderate chronic obstructive pulmonary disease (COPD) and age-matched.

A–f) Respiratory mechanical measurements during incremental cycle exercise in patients with moderate chronic obstructive pulmonary disease (COPD) and age-matched.
A) Healthcare utilisation, b) short form (SF)-12 scores and c) work productivity and activity impairment in patients with asthma (▓) and diabetes (▪) in.

A) Healthcare utilisation, b) short form (SF)-12 scores and c) work productivity and activity impairment in patients with asthma (▓) and diabetes (▪) in.

Similar presentations

Ads by Google